ATLASATLAS fair value
₹2,509
Above fair value · 141% premium
Range: ₹2,258–₹2,760Fair valuePrice
AstraZeneca Pharma India (ASTRAZEN.NSE)
AstraZeneca Pharma India share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India
₹6,052▲ +1.05%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
52%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on AstraZeneca Pharma India in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On AstraZeneca Pharma India
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates AstraZeneca Pharma India's fair value at about ₹2,509 per share (reasonable range: ₹2,258 to ₹2,760). At ₹6,052, the stock trades 141% above it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives AstraZeneca Pharma India a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹5,813 and ₹6,340; in 9 out of 10, between ₹5,382 and ₹6,848. Estimated annual volatility is 20%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹151B
- Market cap (USD)
- $1.6B
- P/E ratio
- 88.3
- Dividend yield
- 0.60%
- 52-week high
- ₹9,850
- 52-week low
- ₹5,640
- Revenue (12 months)
- ₹24.3B
- Operating margin
- 6.4%
- Net margin
- 7.0%
- Beta
- 0.23
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. AstraZeneca Pharma India sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks ASTRAZEN.NSE has traded between ₹5,640 and ₹9,850. Today it is 38.6% below that high and 7% above its low.
On the business: net margin is 7.0%; it trades at 88.3 times earnings.
Its beta is 0.23: it tends to move less than the market.
About the company
AstraZeneca Pharma India Ltd., a significant entity in the pharmaceutical sector, concentrates on manufacturing and marketing a comprehensive range of medicinal products.
Want to see everything about AstraZeneca Pharma India?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is AstraZeneca Pharma India (ASTRAZEN.NSE) fair value?
About ₹2,509 per share according to ATLAS (reasonable range: ₹2,258 to ₹2,760). With the stock at ₹6,052, it is 141% above it.
What is the chance ASTRAZEN.NSE goes up next month?
52%: close to a coin flip. In half of the simulated outcomes, ASTRAZEN.NSE ends the month between ₹5,813 and ₹6,340.
How big is AstraZeneca Pharma India and what is its P/E ratio?
AstraZeneca Pharma India's market capitalization is ₹151B. Its price-to-earnings (P/E) ratio is 88.3: you pay ₹88.3 for each ₹1.00 of yearly earnings.
Does AstraZeneca Pharma India pay a dividend?
Yes. ASTRAZEN.NSE's current dividend yield is 0.60% at today's price (₹6,052).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer